Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Albumin Levels on Cefazolin Pharmacokinetics in Adult Cardiac Surgery Patients
2020-003174-50Phase 4Active
- Sponsor
- Medical University of Vienna
- Start
- Dec 2020
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefazolin in bacterial disease (2 arms), sponsored by Medical University of Vienna. Primary endpoint: AUC0-10 of cefazolin. Started Dec 2020; status: active.
02
Drugs
cefazolin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2020-003174-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003174-50.